13157735 · Active · incorporated 5 years, 9 months ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Series B+
ThirtyFiveBio develops treatments for ulcerative colitis, focusing on a gut epithelial shield and small molecule inhibitors of GPR35.
https://www.thirtyfivebio.com/
Thirtyfivebio Limited is a private limited company registered at Companies House under number 13157735, incorporated on 26 January 2021, with a registered office in Abingdon. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 84 filings for this company, including 2 funding rounds. Its most recent round closed in February 2022, raising £12.5m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Feb 2022 | £12.5m | £7.10 |
| Round 1 | Feb 2021 | £92m | £87.10 |
Showing the 10 most recent of 84 filings.
See the complete cap table with every shareholder, founder tags, dilution across 15 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.